43 related articles for article (PubMed ID: 15193996)
1. Ragaglitazar: a novel PPAR alpha PPAR gamma agonist with potent lipid-lowering and insulin-sensitizing efficacy in animal models.
Chakrabarti R; Vikramadithyan RK; Misra P; Hiriyan J; Raichur S; Damarla RK; Gershome C; Suresh J; Rajagopalan R
Br J Pharmacol; 2003 Oct; 140(3):527-37. PubMed ID: 12970088
[TBL] [Abstract][Full Text] [Related]
2. Peroxisome proliferator-activated receptor alpha target genes.
Mandard S; Müller M; Kersten S
Cell Mol Life Sci; 2004 Feb; 61(4):393-416. PubMed ID: 14999402
[TBL] [Abstract][Full Text] [Related]
3. Will the potential of peroxisome proliferator-activated receptor agonists be realized in the clinical setting?
Blaschke F; Bruemmer D; Law RE
Clin Cardiol; 2004 Jul; 27(7 Suppl 4):IV3-10. PubMed ID: 15470905
[TBL] [Abstract][Full Text] [Related]
4. Increased fibroblast growth factor 21 expression in high-fat diet-sensitive non-human primates (Macaca mulatta).
Nygaard EB; Møller CL; Kievit P; Grove KL; Andersen B
Int J Obes (Lond); 2014 Feb; 38(2):183-91. PubMed ID: 23736354
[TBL] [Abstract][Full Text] [Related]
5. K-111: the emerging evidence for its potential in the treatment of the metabolic syndrome.
Duggan-Keen M
Core Evid; 2006; 1(3):169-80. PubMed ID: 22500152
[TBL] [Abstract][Full Text] [Related]
6. Effects of aleglitazar, a balanced dual peroxisome proliferator-activated receptor α/γ agonist on glycemic and lipid parameters in a primate model of the metabolic syndrome.
Hansen BC; Tigno XT; Bénardeau A; Meyer M; Sebokova E; Mizrahi J
Cardiovasc Diabetol; 2011 Jan; 10():7. PubMed ID: 21251281
[TBL] [Abstract][Full Text] [Related]
7. Sorting out the roles of PPAR alpha in energy metabolism and vascular homeostasis.
Lefebvre P; Chinetti G; Fruchart JC; Staels B
J Clin Invest; 2006 Mar; 116(3):571-80. PubMed ID: 16511589
[TBL] [Abstract][Full Text] [Related]
8. PPAR agonists in the treatment of insulin resistance and associated arterial disease.
Camejo G
Int J Clin Pract Suppl; 2003 Mar; (134):36-44. PubMed ID: 12793596
[TBL] [Abstract][Full Text] [Related]
9. Statins and diabetes.
Carmena R; Betteridge DJ
Semin Vasc Med; 2004 Nov; 4(4):321-32. PubMed ID: 15861314
[TBL] [Abstract][Full Text] [Related]
10. Biochemical and morphological effects of K-111, a peroxisome proliferator-activated receptor (PPAR)alpha activator, in non-human primates.
Schäfer SA; Hansen BC; Völkl A; Fahimi HD; Pill J
Biochem Pharmacol; 2004 Jul; 68(2):239-51. PubMed ID: 15193996
[TBL] [Abstract][Full Text] [Related]
11. The effects of K-111, a new insulin-sensitizer, on metabolic syndrome in obese prediabetic rhesus monkeys.
Bodkin NL; Pill J; Meyer K; Hansen BC
Horm Metab Res; 2003 Oct; 35(10):617-24. PubMed ID: 14605998
[TBL] [Abstract][Full Text] [Related]
12. Improvement of dyslipidemia, insulin sensitivity, and energy balance by a peroxisome proliferator-activated receptor alpha agonist.
Chen X; Matthews J; Zhou L; Pelton P; Liang Y; Xu J; Yang M; Cryan E; Rybczynski P; Demarest K
Metabolism; 2008 Nov; 57(11):1516-25. PubMed ID: 18940388
[TBL] [Abstract][Full Text] [Related]
13. Fibrates induce hepatic peroxisome and mitochondrial proliferation without overt evidence of cellular proliferation and oxidative stress in cynomolgus monkeys.
Hoivik DJ; Qualls CW; Mirabile RC; Cariello NF; Kimbrough CL; Colton HM; Anderson SP; Santostefano MJ; Morgan RJ; Dahl RR; Brown AR; Zhao Z; Mudd PN; Oliver WB; Brown HR; Miller RT
Carcinogenesis; 2004 Sep; 25(9):1757-69. PubMed ID: 15131011
[TBL] [Abstract][Full Text] [Related]
14. A novel peroxisome proliferator--activated receptor alpha/gamma dual agonist ameliorates dyslipidemia and insulin resistance in prediabetic rhesus monkeys.
Ding SY; Tigno XT; Braileanu GT; Ito K; Hansen BC
Metabolism; 2007 Oct; 56(10):1334-9. PubMed ID: 17884441
[TBL] [Abstract][Full Text] [Related]
15. Differential regulation of the cynomolgus, human, and rat acyl-CoA oxidase promoters by PPARalpha.
Kane CD; Francone OL; Stevens KA
Gene; 2006 Oct; 380(2):84-94. PubMed ID: 16828988
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
